About Orbus

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.


Our team is committed to improving the health and quality of life for patients with rare diseases. 


Orbus Therapeutics is developing products for patients fighting   diseases that affect only a small percentage of the population.


We are starting our Phase 3  clinical trial in recurrent anaplastic astrocytoma  patients in 2016.